Skip to main content
Smart Investors Daily
NX

NASDAQ · NXGL

NEXGEL, Inc.

Healthcare · Medical - Instruments & Supplies

$3.35

Down-$0.26 (-7.07%)

Updated Nov 20, 2026, 2:01 AM

SID Score

5.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
19.39M
P/E ratio
-4.77
Dividend yield
0.00%
52-week range
$0.16 – $7.25
Volume
34.23K
Avg. volume
65.95K

Price performance · NXGL

NXGL price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

NXGL closed at $3.35 after 21 trading sessions, down 29.62% for the selected period.

Last close
$3.35
Period change
-29.62%
Period low
$3.35
Period high
$5.03
Daily close
View OHLC price history
NXGL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$3.50$3.58$3.20$3.3534.23K
Nov 18, 2026$3.55$3.84$3.55$3.60512.69K
Nov 17, 2026$3.95$4.07$3.52$3.8012.4K
Nov 16, 2026$3.80$4.04$3.57$3.9344.24K
Nov 13, 2026$3.90$4.07$3.6601$3.8813.64K
Nov 12, 2026$4.11$4.30$3.50$3.7963.21K
Nov 11, 2026$3.62$4.30$3.62$4.2434.2K
Nov 10, 2026$3.54$3.77$3.31$3.5888.27K
Nov 9, 2026$3.37$3.84$3.3379$3.64522.65K
Nov 6, 2026$3.80$3.80$3.60$3.6013.88K
Nov 5, 2026$3.75$4.1175$3.5701$4.117511.43K
Nov 4, 2026$4.48$4.50$3.8002$4.0145.24K
Nov 3, 2026$3.80$4.49$3.69$4.4822.17K
Nov 2, 2026$3.715$4.1499$3.60$3.7918.28K
Oct 30, 2026$3.75$3.895$3.50$3.5160.14K
Oct 29, 2026$3.755$3.98$3.75$3.8814.58K
Oct 28, 2026$4.23$4.30$3.80$4.0353.09K
Oct 27, 2026$3.86$4.255$3.61$4.25561.66K
Oct 26, 2026$4.68$4.7599$3.90$3.9648.51K
Oct 23, 2026$4.72$5.26$4.7122$5.0354.36K
Oct 22, 2026$5.29$5.45$4.7216$4.7631.67K

Latest NXGL news

The latest Smart Investors Daily articles mentioning NXGL.

NXGL research

Overview

Company profile and research snapshot.

Company profile

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
NXGL recent ratings
DateFirmRatingTarget
Aug 24, 2026Maxim GroupHold—
Mar 12, 2026Maxim GroupBuy—
Feb 25, 2022Maxim GroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Oct 27, 2026

NEXGEL Regains Nasdaq Compliance

NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL), a company with a patient-centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.